Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000436301 | SCV000518228 | likely benign | not specified | 2015-08-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000436301 | SCV000703135 | likely benign | not specified | 2016-11-21 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000990912 | SCV000762469 | likely benign | Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked | 2023-10-03 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000990912 | SCV001141965 | likely benign | Rolandic epilepsy, intellectual disability, and speech dyspraxia, X-linked | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001706627 | SCV004167230 | likely benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | SRPX2: BP4, BS2 |
Genome Diagnostics Laboratory, |
RCV001706627 | SCV001931497 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001706627 | SCV001966984 | likely benign | not provided | no assertion criteria provided | clinical testing |